Narayana Hrudayalaya Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Narayana Hrudayalaya Ltd is ₹ 1647 as of 23 Oct 15:30 . The P/E Ratio of Narayana Hrudayalaya Ltd changed from 44.6 on March 2022 to 40.7 on March 2026 . This represents a CAGR of -1.81% over 5 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Narayana Hrudayalaya Ltd changed from ₹ 8299 crore on March 2021 to ₹ 32813 crore on March 2026 . This represents a CAGR of 25.75% over 6 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 2719 crore as compare to the Mar '26 revenue of ₹ 2623 crore. This represent the growth of 3.66% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 503.27 crore as compare to the Mar '26 ebitda of ₹ 533.16 crore. This represent the decline of -5.61% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of Narayana Hrudayalaya Ltd changed from ₹ 201.49 crore to ₹ 207.27 crore over 9 quarters. This represents a CAGR of 1.26% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of Narayana Hrudayalaya Ltd changed from 15.3 % on March 2022 to 18.28 % on March 2026 . This represents a CAGR of 3.62% over 5 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty as its Founder.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It has a network of multispeciality, and super speciality hospitals spread across multiple locations.
The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. During the financial year ended 31 March 2016, Company acquired the entire remaining 26% in Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK) by paying Rs 3,025.60 Lacs as total purchase consideration to make NHSHPL as its wholly owned subsidiary.

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

FAQs for the comparison of Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Narayana Hrudayalaya Ltd or Suven Life Sciences Ltd?

Market cap of Narayana Hrudayalaya Ltd is 33,658 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd?

The stock performance of Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd?

As of October 25, 2026, the Narayana Hrudayalaya Ltd stock price is INR ₹1647.0. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Narayana Hrudayalaya Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.